Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer
Xuan Deng, Fanyang Kong, Si Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway
Guoxiang Tong, Tianhao Peng, Ya Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 61
Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
Alireza Mafi, Malihe Rezaee, Neda Hedayati, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
Xing Peng, Shuo Wang, Yu Cao, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101002-101002
Open Access | Times Cited: 27
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24
Breaking the Barrier: Epigenetic Strategies to Combat Platinum Resistance in Colorectal Cancer
Shiwen Luo, Yue Ming, Dequan Wang, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101152-101152
Open Access | Times Cited: 6
THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
Xing Zhou, Jiashu Han, Anning Zuo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4761-4761
Open Access | Times Cited: 23
Crosstalk between long non-coding RNAs and p53 signaling pathway in colorectal cancer: A review study
Mohammad Mahdi Khanifar, Zahra Zafari, Mohsen Sheykhhasan
Pathology - Research and Practice (2023) Vol. 249, pp. 154756-154756
Closed Access | Times Cited: 15
Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and Metabolomics
Gabriel Cutshaw, Nora Hassan, Saji Uthaman, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 35, pp. 13172-13184
Open Access | Times Cited: 14
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer
Yu Zheng, Jian Wu, Hong Chen, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 13
LncRNAs: the good, the bad, and the unknown
Ganesan Arunkumar
Biochemistry and Cell Biology (2023) Vol. 102, Iss. 1, pp. 9-27
Open Access | Times Cited: 11
Long noncoding RNA GDIL acts as a scaffold for CHAC1 and XRN2 to promote platinum resistance of colorectal cancer through inhibition of glutathione degradation
Xuan Deng, Chang Lu, Ling‐Yu Tang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells
Mostafa Mostafazadeh, Houman Kahroba, Sanya Haiaty, et al.
Cell Biochemistry and Function (2022) Vol. 40, Iss. 4, pp. 391-402
Closed Access | Times Cited: 19
YAP derived circ-LECRC functions as a “brake signal” to suppress hyperactivation of oncogenic YAP signalling in colorectal cancer
Yue An, Boyang Xu, Guanyu Yan, et al.
Cancer Letters (2022) Vol. 532, pp. 215589-215589
Open Access | Times Cited: 18
Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis
Jia He, Wenhan Wu
Non-coding RNA Research (2022) Vol. 8, Iss. 1, pp. 33-52
Open Access | Times Cited: 17
Controllers of histone methylation-modifying enzymes in gastrointestinal cancers
Ling Li, Qing Song, Jing Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116488-116488
Open Access | Times Cited: 3
KLF4: a multifunctional nexus connecting tumor progression and immune regulation
Ying Ju, Wen Xiao, Bryan J. Mathis, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
USF1-activated hsa_circ_0076691 induces oxaliplatin resistance via facilitating FGF9 expression in miR-589-3p-dependent manners
Lingyu Tang, Xuan Deng, Ming Guan, et al.
Non-coding RNA Research (2025)
Open Access
EZH2 mitigates the cardioprotective effects of mesenchymal stem cell-secreted exosomes against infarction via HMGA2-mediated PI3K/AKT signaling
Wei Jiao, Jie Hao, Yanan Xie, et al.
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies
Zhengyue Zhang, Yanjie Zhang
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance
Negin Raei, Reza Safaralizadeh, Mohammadali Hesseinpourfeizi, et al.
Life Sciences (2021) Vol. 284, pp. 119933-119933
Closed Access | Times Cited: 20
Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential
Zheng-Dong Luo, Yifeng Wang, Yu-Xiao Zhao, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 1-18
Open Access | Times Cited: 8
TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach
Tayebeh Cheraghi-shavi, Razieh Jalal, Zarrin Minuchehr
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289535-e0289535
Open Access | Times Cited: 7
Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 4, pp. 615-632
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top